As with KIF20A, KIF23 was also reported to influence sensitivity to cisplatin and sorafenib [51, 88, 89], indicating that either of KIF20A or KIF23, or say this kinesin subfamily might act an essential role in the maintenance of HCC chemo-resistance (Fig. 3B). Here, KIF20A is linked to hepatocellular carcinoma.